OTCMKTS:DCHPF

Dechra Pharmaceuticals - DCHPF Price Target & Analyst Ratings

$31.35

0.00 (0.00%)

(As of 03/31/2023 12:00 AM ET)

Add

Compare

Today's Range: $31.35
▼
$31.35
50-Day Range: $31.35
▼
$37.46
52-Week Range: $27.90
▼
$42.75

Volume: N/A
Average Volume: 843 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Dechra Pharmaceuticals Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 5 Analyst Ratings

Consensus Analyst Price Target

N/A

Type	Current 4/1/22 to 4/1/23	1 Month Ago 3/2/22 to 3/2/23	3 Months Ago 1/1/22 to 1/1/23	1 Year Ago 4/1/21 to 4/1/22
Consensus Rating	Moderate Buy	Moderate Buy	Hold	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Predicted Upside	N/A	N/A	N/A	N/A

Get Dechra Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for DCHPF and its competitors with MarketBeat's FREE daily newsletter.

DCHPF Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DCHPF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Dechra Pharmaceuticals Stock vs. The Competition

Type	Dechra Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	2.80	2.65	2.47
Consensus Rating	Moderate Buy	Buy	Hold
Predicted Upside		1,995.27% Upside	98.15% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target
3/7/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		GBX 4,600 ➝ GBX 4,000
1/12/2023	Panmure Gordon Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
1/10/2023	Liberum Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
10/18/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
10/5/2022	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold
9/15/2022	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		GBX 4,200 ➝ GBX 4,000
9/6/2021	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold

(Data available from 4/1/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

DCHPF Price Target - Frequently Asked Questions

What is Dechra Pharmaceuticals's consensus rating?: According to the issued ratings of 5 analysts in the last year, the consensus rating for Dechra Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 4 buy ratings for DCHPFthe . Learn more on DCHPF's analyst rating history.
Do Wall Street analysts like Dechra Pharmaceuticals more than its competitors?: Analysts like Dechra Pharmaceuticals more than other Medical companies. The consensus rating for Dechra Pharmaceuticals is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how DCHPF compares to other companies.
Is Dechra Pharmaceuticals being upgraded by Wall Street analysts?: Over the previous 90 days, Dechra Pharmaceuticals's stock had 2 upgrades by analysts.

What analysts cover Dechra Pharmaceuticals?: Dechra Pharmaceuticals has been rated by JPMorgan Chase & Co., Liberum Capital, and Panmure Gordon in the past 90 days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

This page (OTCMKTS:DCHPF) was last updated on 4/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial